NIRS advancements improve patient experience, help diagnose diseases

New discoveries have been made in near-infrared spectroscopy technologies (NIRS) that are helping physicians diagnose and treat diseases. The advancement are also reducing costs and portability while increasing sensitivity and patient comfort.

The findings, published in Neurophotonics and the Journal of Biomedical Optics, are strides toward making NIRS part of the everyday clinical routine.

The study covers a wide range of topics like measuring oxygen saturation in muscles and visceral organs, assessing wounds tissue and characterizing tumors.

For more information on the findings, click here.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup